754 search results for “hybrid drug” in the Student website
-
Eline DekeysterFaculty of Social and Behavioural Sciences
-
A future with tailored therapy for patients with atherosclerosis
The AtheroNeth consortium received €6 million from the Dutch Heart Foundation to gain a better understanding of the differences in disease progression among patients with atherosclerosis. The ultimate goal is to enable personalised treatment.
-
Madeline Kavanagh -
Marije Niemeijer -
A faster way to find new medicines – without the limitations of big DNA barcodes
Leiden researchers, led by Sebastian Pomplun developed a new method to screen hundreds of thousands of molecules for drug discovery, using mass spectrometry instead of DNA tags. ‘We wanted to make drug discovery faster and more accessible.’
-
Rob van Wijk -
UMCs join forces to increase pandemic preparedness
Four university medical centres, including the LUMC, are joining forces to increase pandemic preparedness in the Netherlands.
-
From discovery to business: 'In the lab, we often don't realise that we are working to help an immense number of patients'
'It gave our team a big boost to hear that our work was valuable,' says medical chemist Elmer Maurits about the moment they won the Venture Challenge. With their company Iprotics, they want to develop a drug that can better treat patients with autoimmune diseases and blood cancers. 25,000 euros of prize…
-
Mario van der Stelt -
Margo Dona -
Laura de Jong -
Book Presentation of Beyond the Mulatta: Haunted Hybridity in Advertising
Book Presentation | Studium Generale Lecture
-
Anita Liao -
Pim Arntzen -
Erik Danen -
Hybrid workshop: Narrating Highland Heritages of Bhutan
Lecture, Hybrid workshop
-
Roxanne Kieltyka -
Doing Drugs Responsibly! A Primer
Workshop
-
From molecule to model: working together on better antibiotics
How can we combat the growing global health crisis of antibiotic resistance? At Leiden University, researchers are tackling this issue from multiple angles. PhD candidate Vladyslav Lysenko develops and redesigns new antibiotic molecules, while Sebastian Tandar studies how we can use existing antibiotics…
-
Major study offers practical guidance on antibiotic dosing in patients with obesity
Leiden researcher Anne-Grete Märtson brought together a large number of studies to better understand antibiotic dosing in patients with obesity. The publication in a renowned medical journal has already garnered much positive reactions, Märtson says. ‘It’s high time researchers started sharing more…
-
Over a million euros for two studies on solutions to antimicrobial resistance
Two consortia led by Leiden researchers have been awarded over one million euros by the Dutch Research Council and the Ministry of Health, Welfare and Sport to find solutions to antimicrobial resistance.
-
Serkan Aslan -
Leiden scientists join national effort to advance nanomedicine
A Dutch consortium has received €6.7 million to accelerate the development of nanomedicines together with patients. Researchers from Leiden University play a key role in the project.
-
Sebastian Pomplun -
Coen van Hasselt -
Anthe Janssen -
Sandra Irmisch -
How Oncode-PACT is bringing new cancer medicines closer with 325 million in Growth Fund money
How can you ensure that more experimental drugs reach the finish line? At the moment, only one in twenty cancer drugs that are tested on humans makes it to the market. This is an enormous loss for patients and society. With a grant from the National Growth Fund, Oncode-PACT aims to efficiently select…
-
Seeking new concepts to treat diseases
Scientific Director of the Leiden Academic Centre for Drug Research (LACDR) Hubertus Irth: ‘We test substances and look for new concepts for treating disease.’
-
Hermen Overkleeft -
Leiden ‘super antibiotic’ keeps dangerous gut bacterium under control with a low dose
The antibiotic EVG7, developed in Leiden, has proven capable of fighting the dangerous gut bacterium C. difficile with only a minimal dose. What’s more, the bacterium is far less likely to return, a major issue with existing antibiotics. The research was published in Nature Communications.
-
‘Never stop trying’: Barz sees his polymers enter clinical trials
A new class of polymers has been used in patients for the first time. The compound is the first new drug solubilising agent in decades. Introduced in 2014 by chemist Matthias Barz from Leiden University, it offers a unique alternative to current options.
-
Agreements
Read here about the various agreements in place at Leiden University for student and study associations and other student organisations.
-
Olivier Béquignon -
During the next pandemic, this mathematical model will speed up the search for treatment
Do you recall all those drugs that were hastily proposed as potential treatments for COVID-19? In the event of a future pandemic, the goal is to offer an effective treatment more quickly and efficiently. To achieve this, a team led by Coen van Hasselt is developing a platform that can speed up the process…
-
Medical Delta AI for Computational Life Sciences
The fact that scientists are increasingly better able to access molecular cell and tissue data also brings with it a new challenge: how can scientists find the information they need for research among the vast amount of data available?
-
CANCELLED: Gloves are off: When and why allies use cyber weapons in hybrid scenarios?
Lecture
-
Peter Smith
-
Andraniek Evadgian
-
Daisy Batenburg -
Elsa Neubert -
Kim Elbertse -
Irene Pascual Garcia -
Jeroen Codee -
Madouc Bergers made her own enzyme inhibitors for her bachelor’s thesis
For her bachelor’s thesis, Molecular Science and Technology student Madouc Bergers synthesized her own molecule that can inhibit the breakdown of sugars. Although most students do not even manage to make one building block, Madouc made three. Partly because of this, she has been nominated for the Science…
-
Nasi Liu -
Marc Boef
-
Bola Khalil -
Myrtille Koerselman -
Mark Fonteyne